Résistance hormonale, méthylation et cancer du sein - CRCL

Epigenetic reprogramming in small cell lung cancer

Cellular irinotecan resistance in colorectal cancer and overcoming irinotecan refractoriness through various combination trials including DNA

Free Radicals–Mediated Epigenetic Changes and Breast Cancer Progression

Frontiers Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer

Cancers, Free Full-Text

The potential of epigenetic therapy to target the 3D epigenome in endocrine- resistant breast cancer

Association between heat shock factor protein 4 methylation and colorectal cancer risk and potential molecular mechanisms: A bioinformatics study

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer

Cancer du sein RH+ , définitions : Hormono résistance primaire : Progression de la maladie pendant les deux premières années du traitement anti hormonal adjuvant ou pendant les 6 premiers mois d'une

PDF) Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer

Cancer du sein : vers une meilleure prise en charge des patientes traitées au tamoxifène

Résistance hormonale, méthylation et cancer du sein - CRCL

Drug resistance in colorectal cancer: An epigenetic overview - ScienceDirect

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer

DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer - ScienceDirect